Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2026-02-10 @ 3:02 PM
Study NCT ID:
NCT02214004
Status:
UNKNOWN
Last Update Posted:
2018-02-15
First Post:
2014-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women
Sponsor:
Gangnam Severance Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HERAKLES
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None